Stockreport

What New Catalysts Are Shifting the Pulmonx Story for Investors [Yahoo! Finance]

Pulmonx Corporation  (LUNG) 
US:NASDAQ Investor Relations: investor.prolunginc.com/investor-relations
PDF Pulmonx's latest price target update keeps fair value steady at $5.75 per share while slightly lowering the discount rate to reflect a modestly reduced risk profile. Wit [Read more]